QuickView for receptor serine/threonine kinase binding (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

There were no matches for receptor serine/threonine kinase binding

1. Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resi…
2. Immune Monitoring in Metastatic Melanoma
3. Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor …
4. Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
5. The Effect of the Preoperative Oral Carbohydrate Attenuating Immediate Postoperative Insulin Resista…